In a comparison of the matched DCIS and invasive components of the same tumors we demonstrated that the genetic changes in the two components were similar in terms of HER2, C-MYC and CCND1 gene amplification. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.